KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Research & Development (2016 - 2025)

Historic Research & Development for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $766.0 million.

  • Abbott Laboratories' Research & Development rose 743.34% to $766.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 576.03%. This contributed to the annual value of $2.8 billion for FY2024, which is 375.78% up from last year.
  • Latest data reveals that Abbott Laboratories reported Research & Development of $766.0 million as of Q3 2025, which was up 743.34% from $725.0 million recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Research & Development peaked at $782.0 million during Q3 2022, and registered a low of $654.0 million during Q1 2021.
  • Over the past 5 years, Abbott Laboratories' median Research & Development value was $700.0 million (recorded in 2023), while the average stood at $706.4 million.
  • In the last 5 years, Abbott Laboratories' Research & Development skyrocketed by 1636.9% in 2022 and then tumbled by 1406.65% in 2023.
  • Over the past 5 years, Abbott Laboratories' Research & Development (Quarter) stood at $762.0 million in 2021, then decreased by 4.86% to $725.0 million in 2022, then fell by 3.45% to $700.0 million in 2023, then rose by 7.0% to $749.0 million in 2024, then increased by 2.27% to $766.0 million in 2025.
  • Its Research & Development was $766.0 million in Q3 2025, compared to $725.0 million in Q2 2025 and $716.0 million in Q1 2025.